Specific suppression of human tumor necrosis factor-α synthesis by antisense oligodeoxynucleotides

Antisense and Nucleic Acid Drug Development

Volumn 6, Issue 4, 1996, Pages 291-299

  Hartmann, Gunther ^a   Krug, Anne ^a   Eigler, Andreas ^a   Moeller, Jochen ^a   Murphy, John ^b   Albrecht, Richard ^b   Endres, Stefan ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; LIPID; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA SEQUENCE; DRUG DNA INTERACTION; DRUG STRUCTURE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; RADIOIMMUNOASSAY; START CODON; STRUCTURE ACTIVITY RELATION;

EID: 0030463625     PISSN: 10872906     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.1.1996.6.291     Document Type: Article

References (3)

1. ABKEN, H., FLUCK, J., and WILLECKE, K. (1992). Four cell-secreted cytokines act synergistically to maintain long-term proliferation of human B cell lines in vitro. J. Immunol. 149, 2785-2794.
2. ALT, M., RENZ, R., HOFSCHNEIDER, P.H., PAUMGARTNER, G., and CASELMANN, W.H. (1995). Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides. Hepatology 22, 707-717.
3. ZUCALI, J.R., and MOREB, J. (1990). Use of antisense oligonucleotides to inhibit monocyte derived cytokines. In: Molecular and Cellular Biology of Cytokines. J J. Oppenheim, M.C. Powanda, M.K. Kluger, and C.A. Dinarello, eds. (Wiley-Liss, Inc., New York), pp. 315-320.